Search Results 101-110 of 1209 for truththere'

  1. TQIP: Advancing trauma care through data-driven benchmarking - Mayo Clinic

    U.S. trauma centers collect and submit data to ACS TQIP. Each member center can then use the aggregate data to benchmark with peer institutions, ...

  2. ONC Real World Testing at Mayo Clinic for Public Health Reporting via Electronic Laboratory Reporting (ELR)

    Mayo Clinic Lab Registry assigns reportable test results from Mayo Clinic's Department of Lab Medicine and Pathology (DLMP) and produces ELR data to meet ...

  3. A Study to Evaluate Digital Biomarkers Linked to Opioid Use Disorder - Mayo Clinic

    Inclusion Criteria: Diagnosed with Opioid Use Disorder (OUD). Willing to participate and follow MAT program rules or enrolled in a residential treatment ...

  4. Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer - Mayo Clinic

    Drugs used in chemotherapy, such as efatutazone dihydrochloride and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the ...

  5. Comparison of the Diagnostic Accuracy of Fujifilm Endoscopic Hypoxia Imaging (FEHI) to Indocyanine Green Fluorescein Imaging in Assessing Intraoperative Tissue Ischemia in Gastrointestinl Surgery - Mayo Clinic

    Comparison of the Diagnostic Accuracy of Fujifilm Endoscopic Hypoxia Imaging (FEHI) to Indocyanine Green Fluorescein Imaging in Assessing Intraoperative Tissue ...

  6. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of Medicine and Science.

  7. S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer - Mayo Clinic

    About this study. RATIONALE: Lymphadenectomy may remove tumor cells that have spread to nearby lymph nodes in patients with invasive bladder cancer.

  8. Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055) - Mayo Clinic

    This is a study of single-agent pembrolizumab in participants with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) who have progressed ...

  9. Gastroenterology and Hepatology - Clinical trials

    The objective of this study is to compare the central neural circuitry with fMRI (7T) in 30 asymptomatic healthy controls, 30 constipated patients without ...

  10. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...